A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil [tigecycline] In Usual Health Care Setting.
Phase of Trial: Phase IV
Latest Information Update: 15 Jul 2011
At a glance
- Drugs Tigecycline (Primary)
- Indications Bacterial infections; Intra-abdominal infections; Skin infections
- Focus Therapeutic Use
- Sponsors Pfizer; Wyeth
- 24 Nov 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2010 Planned number of patients changed to 1028 as reported by ClinicalTrials.gov.